Girihlet
T-cell sequencing to monitor health
* Data source: Crunchbase
- Founded
- 2012
- Employees*
- 1-10
- Funding to Date*
- $2.8M
- Website
- girihlet.com
We think measuring your immune system is a more complete window to your health because it’s highly dynamic, predictive, and retains memories of past events.
Your immune system is the first one to detect cancer cells
The complexity and growing prevalence of autoimmune disorders demands attention. Baked into our immune cells are records of the interplay between the genome, diet, and the environment.
Girihlet’s patented approach to sequencing T-cell receptors (TCR) unlocks these complex interactions by classifying TCRs into actionable biomarkers to diagnose and identify treatment avenues for autoimmune diseases.